Video content of Kevin Cook | Talkmarkets
Senior Stock Strategist
Contributor's Links: Zacks

Kevin Cook was a high-frequency institutional currency trader for nine years, starting with the introduction of the euro currency in 1999. Trading 100 million per day in the hyper-kinetic world of FX spot-futures arbitrage, and making continuous markets for size to the biggest banks and hedge ... more


Latest Posts
1 to 16 of 16 Posts
Nvidia GTC Blows Your Mind, Every Time
In today's Cook's Kitchen we review the logic of why you always buy the dips in the King of AI.
Software Valuations: How To Use The Rule Of 40
The Rule of 40 metric for determining a software company's attractiveness to investors is a simple guide that often explains why they pay so much for "growth at a ridiculous price".
ESG Investing: Does It Distort The Market?
According to the Nasdaq exchange, ESG-integrated strategies assets under management (AUM) were $8.2 trillion as of the end of 2020, up 34% from the end of 2018. More on Nasdaq research coming up.
Alzheimer's Disease: 5 Stocks On Biotech Radars
What's been interesting for the past couple of years, and especially the last few months, is to watch the rise of emerging, small-cap Biotech companies trying to take on the big AD and other neurological and CNS diseases.
Tesla To $6,000 And SpaceX To The Moon?
Did you hear the one about the investor who just raised her price target on Tesla shares from $4,000 to $6,000 by 2025?
The Not-Good-Enough Earnings Season
Charts say that fund managers are still cautious about a potential earnings peak and better buys are yet to come. Video length: 00:12:35.
Inside The Mind Of Bill Ackman As Valeant Collapsed
Valeant Pharmaceuticals stock was trading around $260 per share at its peak in the summer of 2015. Today, it’s trading $15. Lets re-cap one of the biggest stock market implosions of the past 18 months.
Oil "Redetermination" Season Looms
Earnings estimates for the first quarter of 2016 are projected to show a decline of 10% in year-over-year growth. Take away the impact from decimated Energy sector profits and the picture is a little brighter at only minus 5% “growth.”
Bear Hunt FOMO Melt-Up
I have a confession: I have been a stock market bear this year. “But I had a great reason,” you can hear me say. My reason was the Earnings Recession.
Synthetic Stock: How Ackman Doubled-Down On VRX
Some may get tired of hearing about Bill Ackman and Valeant Pharma, but I think studying this investment – its ups, downs, tricks, and traps – is a fascinating study in both the power of derivatives and that of investing bias.
Correction Roadmap Update: 2011 Recession Fear Was Greater
At S&P 2000 we are back to trading at nearly 17X 2016 estimates of $120. That’s rich while headed into an earnings recession.
Trading The VIX: What You Need To Know
So you think you’re ready to trade the VIX through its futures, options, or ETFs. I’ve got news for you: most traders have no idea what they are looking at when it comes to anything to do with the VIX.
6 Ingredients For 3% GDP
Fresh fundamental data to show why the economy is due for a big and sustained rebound into 2016.
6 Linchpins Of The Aging Bull
The so-called "whales" of the investing ocean have studied numerous market cycles and they want to make sure they are putting their clients' money in the strongest and steadiest currents. Make sure you understand the linchpins they are focused on.
Why The Bull Isn't Done Running
Why do so many investors waste so much time trying to predict the top of this bull market? (Video length 00:16:05)
Machines Rule, Bears Drool
The S&P 500 and Nasdaq 100 have been masking the broad market selling that is obvious if you look at other indexes breaking below their 100-day moving averages.
1 to 16 of 16 Posts